Siegel RL, Miller KD, Goding Sauer A, Fedewa SA, Butterly LF, Anderson JC, Cercek A, Smith RA, Jemal A. Colorectal cancer statistics, 2020. Cancer J Clin. 2020;70:145–64.
Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
Siegel RL, Miller KD, Wagle NS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73:17–48.
Song M, Chan AT, Sun J. Influence of the gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer. Gastroenterology. 2020;158:322–40.
Article CAS PubMed Google Scholar
Simon K. Colorectal cancer development and advances in screening. Clin Interv Aging. 2016;11:967–76.
Article CAS PubMed PubMed Central Google Scholar
Chetroiu D, Pop CS, Filip PV, Beuran M. How and why do we screen for colorectal cancer? J Med Life. 2021;14:462–7.
Article PubMed PubMed Central Google Scholar
Levin TR, Corley DA, Jensen CD, Schottinger JE, Quinn VP, Zauber AG, Lee JK, Zhao WK, Udaltsova N, Ghai NR, et al. Effects of Organized Colorectal Cancer Screening on Cancer incidence and mortality in a large community-based Population. Gastroenterology. 2018;155:1383–e13911385.
Shaukat A, Levin TR. Current and future colorectal cancer screening strategies. Nat Reviews Gastroenterol Hepatol. 2022;19:521–31.
Hanna M, Dey N, Grady WM. Emerging tests for Noninvasive Colorectal Cancer Screening. Clin Gastroenterol Hepatol. 2023;21:604–16.
Imperiale TF, Ransohoff DF, Itzkowitz SH. Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014;371:187–8.
Barnell EK, Wurtzler EM, La Rocca J, Fitzgerald T, Petrone J, Hao Y, Kang Y, Holmes FL, Lieberman DA. Multitarget Stool RNA test for Colorectal Cancer Screening. JAMA. 2023;330:1760–8.
Article CAS PubMed PubMed Central Google Scholar
Bosch LJW, de Wit M, Pham TV, Coupé VMH, Hiemstra AC, Piersma SR, Oudgenoeg G, Scheffer GL, Mongera S, Sive Droste JT, et al. Novel stool-based protein biomarkers for Improved Colorectal Cancer Screening: a case-control study. Ann Intern Med. 2017;167:855–66.
Iadsee N, Chuaypen N, Techawiwattanaboon T, Jinato T, Patcharatrakul T, Malakorn S, Petchlorlian A, Praditpornsilpa K, Patarakul K. Identification of a novel gut microbiota signature associated with colorectal cancer in Thai population. Sci Rep. 2023;13:6702.
Article CAS PubMed PubMed Central Google Scholar
Nikanjam M, Kato S, Kurzrock R. Liquid biopsy: current technology and clinical applications. J Hematol Oncol. 2022;15:131.
Article CAS PubMed PubMed Central Google Scholar
Marcuello M, Vymetalkova V, Neves RPL, Duran-Sanchon S, Vedeld HM, Tham E, van Dalum G, Flugen G, Garcia-Barberan V, Fijneman RJ, et al. Circulating biomarkers for early detection and clinical management of colorectal cancer. Mol Aspects Med. 2019;69:107–22.
Article CAS PubMed Google Scholar
Ashworth TR. A case of cancer in which cells similar to those in the tumors were seen in the blood after death. 1869.
Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20:69–84.
Article CAS PubMed Google Scholar
Lozar T, Gersak K, Cemazar M, Kuhar CG, Jesenko T. The biology and clinical potential of circulating tumor cells. Radiol Oncol. 2019;53:131–47.
Article PubMed PubMed Central Google Scholar
Rawal S, Yang YP, Cote R, Agarwal A. Identification and quantitation of circulating Tumor cells. Annu Rev Anal Chem (Palo Alto Calif). 2017;10:321–43.
Article CAS PubMed Google Scholar
Franken A, Kraemer A, Sicking A, Watolla M, Rivandi M, Yang L, Warfsmann J, Polzer BM, Friedl TWP, Meier-Stiegen F, et al. Comparative analysis of EpCAM high-expressing and low-expressing circulating tumour cells with regard to their clonal relationship and clinical value. Br J Cancer. 2023;128:1742–52.
Article CAS PubMed PubMed Central Google Scholar
Racila E, Euhus D, Weiss AJ, Rao C, Mcconnell J, Terstappen LW, Uhr JW. Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci USA 1998:95.
Tamminga M, Andree KC, Hiltermann TJN, Jayat M, Schuuring E, van den Bos H, Spierings DCJ, Lansdorp PM, Timens W, Terstappen LWMM, Groen HJM. Detection of Circulating Tumor Cells in the Diagnostic Leukapheresis Product of Non-Small-Cell Lung Cancer Patients Comparing CellSearch® and ISET. Cancers 2020, 12.
Rushton AJ, Nteliopoulos G, Shaw JA, Coombes RC. A review of circulating Tumour Cell Enrichment technologies. Cancers 2021, 13.
Tian D, Zhang M, Zheng G, Zhang Y, Li Y, Lin P, Li H, Jiao W, Niu H. Clinical significance of phenotyping and karyotyping of detecting circulating tumor cells in renal cell carcinoma using subtraction enrichment and immunostaining-fluorescence in situ hybridization (SE-iFISH). Int Urol Nephrol. 2020;52:2281–7.
Article CAS PubMed Google Scholar
Hu B, Gong Y, Wang Y, Xie J, Cheng J, Huang Q. Comprehensive Atlas of circulating rare cells detected by SE-iFISH and Image scanning platform in patients with various diseases. Front Oncol. 2022;12:821454.
Article CAS PubMed PubMed Central Google Scholar
Xia C, Dong X, Li H, Cao M, Sun D, He S, Yang F, Yan X, Zhang S, Li N, Chen W. Cancer statistics in China and United States, 2022: profiles, trends, and determinants. Chin Med J (Engl). 2022;135:584–90.
Lakemeyer L, Sander S, Wittau M, Henne-Bruns D, Kornmann M, Lemke J. Diagnostic and prognostic value of CEA and CA19-9 in Colorectal Cancer. Diseases 2021, 9.
Gandon Y. Screening for colorectal cancer: the role of CT colonography. Diagn Interv Imaging. 2014;95:467–74.
Article CAS PubMed Google Scholar
Kaminski MF, Robertson DJ, Senore C, Rex DK. Optimizing the quality of Colorectal Cancer Screening Worldwide. Gastroenterology. 2020;158:404–17.
Adler A, Geiger S, Keil A, Bias H, Schatz P, deVos T, Dhein J, Zimmermann M, Tauber R, Wiedenmann B. Improving compliance to colorectal cancer screening using blood and stool based tests in patients refusing screening colonoscopy in Germany. BMC Gastroenterol. 2014;14:183.
Article PubMed PubMed Central Google Scholar
Tsai WS, You JF, Hung HY, Hsieh PS, Hsieh B, Lenz HJ, Idos G, Friedland S, Yi-Jiun Pan J, Shao HJ, et al. Novel circulating Tumor Cell Assay for detection of colorectal adenomas and Cancer. Clin Transl Gastroenterol. 2019;10:e00088.
Article PubMed PubMed Central Google Scholar
Hatzidaki E, Iliopoulos A, Papasotiriou I. A Novel Method for Colorectal Cancer Screening based on circulating Tumor cells and machine learning. Entropy (Basel) 2021, 23.
Tsai WS, Hung WS, Wang TM, Liu H, Yang CY, Wu SM, Hsu HL, Hsiao YC, Tsai HJ, Tseng CP. Circulating tumor cell enumeration for improved screening and disease detection of patients with colorectal cancer. Biomed J. 2021;44:S190–200.
Article CAS PubMed Google Scholar
Baek DH, Kim GH, Song GA, Han IS, Park EY, Kim HS, Jo HJ, Ko SH, Park DY, Cho YK. Clinical potential of circulating Tumor cells in Colorectal Cancer: a prospective study. Clin Transl Gastroenterol. 2019;10:e00055.
Article PubMed PubMed Central Google Scholar
Oh BY, Kim J, Lee WY, Kim HC. A new size-based platform for circulating Tumor Cell detection in Colorectal Cancer patients. Clin Colorectal Cancer. 2017;16:214–9.
Morris VK, Kennedy EB, Baxter NN, Benson AB 3rd, Cercek A, Cho M, Ciombor KK, Cremolini C, Davis A, Deming DA, et al. Treatment of metastatic colorectal Cancer: ASCO Guideline. J Clin Oncol. 2023;41:678–700.
Comments (0)